Regeneron Jumps on ‘Ultimate Validation’ as Trump Treated

(Bloomberg) -- Regeneron Pharmaceuticals Inc. climbed the most in more than three months on Monday after U.S. President Donald Trump received the biotech company’s antibody cocktail to treat Covid-...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.